Recent Company News

• 11:17 AM ET Jun 11, 2026
  

  StreetAccount Summary - US unusual volume traders

• 08:04 AM ET Jun 03, 2026
  

  Arcus Biosciences announces clinical trial collaboration and supply agreement to evaluate casdatifan in combination with Pd‑L1/VEGF‑a bispecific Immunomodulator to treat kidney cancer ($24.47, 0.00)

• 02:50 PM ET May 30, 2026
  

  BioNTech announces interim Phase 2 data from the global Phase 2/3 ROSETTA Lung-02 clinical trial ($95.95, 0.00)

• 02:11 PM ET May 29, 2026
  

  StreetAccount Summary: Notable Drug Events expected for the week of 31-May

• 11:52 AM ET May 29, 2026
  

  EC approves update to MAA for Comirnaty in youngest children ($25.99, -0.15)

• 02:27 PM ET May 28, 2026
  

  FDA panel votes 8-0-1 to recommend JN.1-lineage XFG variant for the 2026-27 formula of COVID-19 vaccine

• 08:45 AM ET May 27, 2026
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 04:59 PM ET May 27, 2026
  

  StreetAccount Sector Summary - Healthcare Post-Market

• 08:22 AM ET May 27, 2026
  

  StreetAccount Summary - US Pre-market trading